| 2024-03-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 250,000 0.2068% | $64.11 | $16.03M | -25.65% | |
| 2024-02-12 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 3,962 0.0034% | $67.77 | $268,492 | -27.14% | |
| 2024-01-29 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 2,843 0.0024% | $64.14 | $182,345 | -19.54% | |
| 2024-01-22 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 13,431 0.0113% | $65.00 | $872,961 | -15.29% | |
| 2024-01-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 7,851 0.0066% | $66.81 | $524,514 | -16.92% | |
| 2023-11-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 5,000 0.0042% | $48.80 | $244,000 | +14.16% | |
| 2023-09-01 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 150,000 0.1223% | $41.75 | $6.26M | +12.6% | |
| 2023-05-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 30,000 0.0257% | $85.66 | $2.57M | -37.13% | |
| 2023-04-18 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 30,000 0.0263% | $82.02 | $2.46M | -28.8% | |
| 2023-03-21 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 30,000 0.0266% | $62.74 | $1.88M | +0.05% | |
| 2022-12-19 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 28,200 0.0258% | $52.06 | $1.47M | +1.22% | |
| 2020-12-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0132% | $52.16 | $521,600 | -11.66% | |
| 2020-11-16 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0136% | $39.38 | $393,800 | +24.12% | |
| 2020-10-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.013% | $34.46 | $344,600 | +34.86% | |
| 2020-09-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0131% | $30.96 | $309,600 | +52.88% | |
| 2020-08-20 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 6,914 0.0089% | $30.00 | $207,420 | +50.71% | |
| 2020-08-18 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 3,086 0.0042% | $30.00 | $92,580 | +59.61% | |
| 2020-07-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0128% | $32.12 | $321,200 | +36.46% | |
| 2020-06-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0123% | $30.21 | $302,100 | +32.4% | |
| 2020-05-15 | Sale | Apellis Pharmaceuticals, Inc. APLS | Chief Executive Officer | 10,000 0.0128% | $29.92 | $299,200 | +23.87% |